Upexi (UPXI) risk factors, FY2025 10-K

Risks Related to Upexi

1. 01Upexi does not anticipate paying any dividends on its common stockNew
2. 02You may experience additional dilution in the futureNew
3. 03Shares eligible for future sale may adversely affect the marketNew
4. 04Our limited operating history makes it difficult for potential investors to evaluate our business prospects and management
5. 05If we are unable to protect our intellectual property rights, our competitive position could be harmed
6. 06We may not be able to effectively manage growth
7. 07Our management may not be able to control costs in an effective or timely manner
8. 08We expect our quarterly financial results to fluctuate
9. 09We are subject to the reporting requirements of U.S. federal securities laws, which can be expensive
10. 10We may incur significant costs and require significant management resources to evaluate our internal control over financial reporting as required under Section 404 of the Sarbanes-Oxley Act, and any failure to comply or any adverse result from such evaluation may have an adverse effect on our stock price
11. 11Increases in costs, disruption of supply or shortage of raw materials could harm our business
12. 12Our failure to meet the continuing listing requirements of the NASDAQ Capital Market could result in a de-listing of our securities
13. 13We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our operating results

Risks Relating to Our Business and Industry

1. 14We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected
2. 15Unfavorable publicity or consumer perception of our products or similar products developed and distributed by other companies could have a material adverse effect on our reputation, which could result in decreased sales and fluctuations in our business, financial condition and results of operations
3. 16Our failure to appropriately and timely respond to changing consumer preferences and demand for new products could significantly harm our customer relationships and have a material adverse effect on our business, financial condition and results of operations
4. 17Future acquisitions or strategic investments and partnerships could be difficult to identify and integrate with our business, disrupt our business, and adversely affect our financial condition and results of operations
5. 18Failure to successfully integrate acquired businesses and their products and other assets into our Company, or if integrated, failure to further our business strategy, may result in our inability to realize any benefit from such acquisition
6. 19The failure to attract and retain key employees could hurt our business
7. 20We have limited supply sources, and price increases or supply shortages of key raw materials could materially and adversely affect our business, financial condition and results of operations
8. 21Loss of key contracts with our suppliers, renegotiation of such agreements on less favorable terms or other actions these third parties may take could harm our business
9. 22There is limited availability of clinical studies
10. 23We face substantial risk of product liability claims and potential adverse product publicity
11. 24We may be unable to attract and retain independent distributors for our products
12. 25competition in the market
13. 26We could incur obligations resulting from the activities of our independent distributors
14. 27If our independent distributors’ failure to comply with applicable advertising laws and regulations could adversely affect our financial conditions and results of operations

Risks Related to the CBD Industry

1. 28Laws and regulations affecting the CBD industry are evolving under the Farm Bill, and changes to applicable regulations may materially affect our future operations in the CBD market
2. 29Unfavorable interpretations of laws governing hemp processing activities could subject us to enforcement or other legal proceedings and limit our business and prospects
3. 30Costs associated with compliance with various laws and regulations could negatively impact our financial results
4. 31Uncertainty caused by potential changes to legal regulations could impact the use and acceptance of CBD products
5. 32If we fail to obtain necessary permits, licenses and approvals under applicable laws and regulations, our business and plan of operations may be adversely impacted
6. 33Potential future international expansion of our business could expose us to additional regulatory risks and compliance costs
7. 34The market for health and wellness products is highly competitive. If we are unable to compete effectively in the market, our business and operating results could be materially and adversely affected

Risks Relating to Investing in Solana

1. 35The launch of central bank digital currencies (“CBDCs”) may adversely impact our businessNew
2. 36Absent federal regulations, there is a possibility that Solana may be classified as a “security.” Any classification of Solana as a “security” would subject us to additional regulation and could materially impact the operation of our businessNew
3. 37If we were deemed to be an investment company under the 1940 Act, applicable restrictions likely would make it impractical for us to continue segments of our business as currently contemplatedNew
4. 38We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operationsNew
5. 39Our Management relies upon the advice of an asset manager through an asset management agreement to assist in building a narrowly focused investment strategy and the execution of the Company’s strategy and may not yield the desired returnNew
6. 40We may use the net proceeds from any offering by the Company to purchase additional Solana, the price of which has been, and will likely continue to be, highly volatileNew
7. 41Our Solana holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalentsNew
8. 42We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisersNew
9. 43significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, contractual and financial exposureNew
10. 44Until recently, our business focus was as a brand owner specializing in the development, manufacturing, and distribution of consumer products. We reach consumers through our direct-to-consumer network, wholesale partnerships, and major third-party platforms like AmazonNew
11. 45If the digital asset award or transaction fees for recording transactions on the Solana network are not sufficiently high to incentivize validators may demand high transaction fees, which could negatively impact the value of SOL and the value of the SharesNew
12. 46A reduction in the digital assets staked by validators on the Solana network could increase the likelihood of a malicious actor or botnet (a volunteer or hacked collection of computers controlled by networked software coordinating the actions of the computers) obtaining controlNew
13. 47Our trading orders may not be timely executedNew
14. 48Competition from other companies staking and utilizing Solana in their treasury plansNew
15. 49Competition from central bank digital currencies (“CBDCs”) and emerging payments initiatives involving financial institutions could adversely affect the price of SOL and other digital assetsNew
16. 50Competition from the emergence or expansion of other digital assets may negatively influence the price of SOL and have an adverse impact on the value of the SharesNew
17. 51We may fail to develop and execute successful investment or trading strategiesNew
18. 52We may make, or otherwise be subject to, trade errorsNew